Cargando…

Treatment of High Blood Pressure and Gain in Event-Free Life Expectancy

OBJECTIVE: Consideration of absolute risk has been recommended for making decisions concerning preventive treatment in hypertension. We performed simulations to estimate the benefit of antihypertensive therapy over a life-time. METHODOLOGY: The rate of nonfatal and fatal events of untreated hyperten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kassaï, Behrouz, Boissel, Jean-Pierre, Cucherat, Michel, Boutitie, Florent, Gueyffier, François
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2005
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993937/ https://www.ncbi.nlm.nih.gov/pubmed/17315403

Ejemplares similares

Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials
por: Boussageon, Rémy, et al.
Publicado: (2012)

Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review
por: Boussageon, Rémy, et al.
Publicado: (2013)

The Global Risk Approach Should Be Better Applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies
por: Marchant, Ivanny, et al.
Publicado: (2011)

High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention
por: Marchant, Ivanny, et al.
Publicado: (2015)

GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis
por: Grenet, Guillaume, et al.
Publicado: (2019)

Publication language and the estimate of treatment effects of physical therapy on balance and postural control after stroke in meta-analyses of randomised controlled trials
por: Hugues, Aurélien, et al.
Publicado: (2020)

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
por: Boussageon, Rémy, et al.
Publicado: (2011)

Gains in Disability-Free Life Expectancy From Elimination of Diseases and Injuries in Japan
por: Hashimoto, Shuji, et al.
Publicado: (2012)

Gains in Life Expectancy Associated with Higher Education in Men
por: Bijwaard, Govert E., et al.
Publicado: (2015)

The slowing pace of life expectancy gains since 1950
por: Cardona, Carolina, et al.
Publicado: (2018)

Whites but Not Blacks Gain Life Expectancy from Social Contacts
por: Assari, Shervin
Publicado: (2017)

Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
por: Erpeldinger, Sylvie, et al.
Publicado: (2016)

The Monetary Valuation of Lifetime Health Improvement and Life Expectancy Gains in Turkey
por: Ara, Shihomi, et al.
Publicado: (2017)

From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not Work
por: Boissel, Jean-Pierre, et al.
Publicado: (2019)

Virtual Patients and Sensitivity Analysis of the Guyton Model of Blood Pressure Regulation: Towards Individualized Models of Whole-Body Physiology
por: Moss, Robert, et al.
Publicado: (2012)

Longevity in Slovenia: Past and potential gains in life expectancy by age and causes of death
por: Lotrič Dolinar, Aleša, et al.
Publicado: (2017)

The Contribution of Avoidable Mortality to the Life Expectancy Gains in Korea between 1998 and 2017
por: Bahk, Jinwook, et al.
Publicado: (2020)

Impact of Elevated Systolic Blood Pressure Levels on Mortality and Life Expectancy in Southeast Chinese Residents
por: Feng, Wei, et al.
Publicado: (2021)

Socioeconomic disparities in life expectancy gains among retired German men, 1997–2016
por: Wenau, Georg, et al.
Publicado: (2019)

Impact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Le, Hai-Ha, et al.
Publicado: (2016)

The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial
por: Lion-François, Laurence, et al.
Publicado: (2014)

Fruit and vegetable consumption and its contribution to inequalities in life expectancy and disability-free life expectancy in ten European countries
por: Baars, Adája E., et al.
Publicado: (2019)

Decreases in Diabetes-Free Life Expectancy in the U.S. and the Role of Obesity
por: Cunningham, Solveig A., et al.
Publicado: (2011)

Trends in Disability-Free Life Expectancy in Japan, 1995–2004
por: Hashimoto, Shuji, et al.
Publicado: (2010)

Living arrangements and disability-free life expectancy in the United States
por: Chiu, Chi-Tsun
Publicado: (2019)

Focus on disability-free life expectancy: implications for health-related quality of life
por: Galvin, Ashley E., et al.
Publicado: (2021)

Does the Sentinel Lymph Node Sampling Alone Improve Quality of Life in Early Cervical Cancer Management?
por: Gianoni, Martina, et al.
Publicado: (2020)

Effects of a multifaceted intervention on cardiovascular risk factors in high-risk hypertensive patients: the ESCAPE trial, a pragmatic cluster randomized trial in general practice
por: Pouchain, Denis, et al.
Publicado: (2013)

Potential gains in life expectancy by reducing inequality of lifespans in Denmark: an international comparison and cause-of-death analysis
por: Aburto, José Manuel, et al.
Publicado: (2018)

Africa Rising, a Narrative for Life Expectancy Gains? Evidence from a Health Production Function
por: Salami, Donald, et al.
Publicado: (2019)

A Web-Based Tool for Quantification of Potential Gains in Life Expectancy by Preventing Cause-Specific Mortality
por: Chandran, Aruna, et al.
Publicado: (2021)

Socioeconomic Position Across the Life Course and Trends in Disability-Free Life Expectancy in Australia
por: Kiely, Kim, et al.
Publicado: (2020)

Socioeconomic inequalities in life expectancy and disability-free life expectancy among Chilean older adults: evidence from a longitudinal study
por: Moreno, Ximena, et al.
Publicado: (2021)

Trends in cancer-free working life expectancy based on health insurance data from Germany–Is the increase as strong as in working life expectancy?
por: Tetzlaff, Fabian, et al.
Publicado: (2023)

Multimorbidity, Disadvantage, and Trends in Disability-Free Life Expectancy: The CFAS Studies
por: Kingston, Andrew, et al.
Publicado: (2020)

Why Are Inequalities in Disability-Free Life Expectancy by Socioeconomic Position Widening?
por: Jagger, Carol
Publicado: (2020)

The Impact of Smoking and Obesity on Disability-Free Life Expectancy in Older Australians
por: Kingston, Andrew, et al.
Publicado: (2020)

Gender and education inequalities in dynapenia-free life expectancy: ELSI-Brazil
por: Borges, Viviane Santos, et al.
Publicado: (2022)

Gestational weight gain, nutritional status and blood pressure in pregnant women
por: Campos, Chiara Alzineth Silva, et al.
Publicado: (2019)

Investigation of 2‐stage meta‐analysis methods for joint longitudinal and time‐to‐event data through simulation and real data application
por: Sudell, Maria, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kk0900v828m209om8a4ohu2si7